Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/72110
Type: Artigo de Periódico
Title: On the synthesis of quinone-based BODIPY hybrids: new insights on antitumor activity and mechanism of action in cancer cells
Authors: Talita Bárbara Gontijo
Rossimiriam Pereira de Freitas
Flavio da Silva Emery
Leandro Ferreira Pedrosa
José de Brito Vieira Neto
Bruno Coêlho Cavalcanti
Claudia do Ó Pessoa
Aaron King
Fabio de Moliner
Marc Vendrell
Eufrânio Nunes da Silva Júnior
Abstract: Fluorescent quinone-based BODIPY hybrids were synthesised and characterised by NMR analysis and mass spectrometry. We measured their cytotoxic activity against cancer and normal cell lines, performed mechanistic studies by lipid peroxidation and determination of reduced (GSH) and oxidized (GSSG) glutathione, and imaged their subcellular localisation by confocal microscopy. Cell imaging experiments indicated that nor-β-lapachone-based BODIPY derivatives might preferentially localise in the lysosomes of cancer cells. These results assert the potential of hybrid quinone-BODIPY derivatives as promising prototypes in the search of new potent lapachone antitumor drugs.
Subject: Quinona
Síntese
Células cancerosas
Ressonância magnética nuclear
Espectrometria de massa
Peroxidação
Glutationa
Microscopia
Agentes antineoplásicos
language: eng
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: ICX - DEPARTAMENTO DE QUÍMICA
Rights: Acesso Restrito
metadata.dc.identifier.doi: https://doi.org/10.1016/j.bmcl.2017.08.007
URI: http://hdl.handle.net/1843/72110
Issue Date: 2017
metadata.dc.url.externa: https://www.sciencedirect.com/science/article/pii/S0960894X17307941
metadata.dc.relation.ispartof: Bioorganic & Medicinal Chemistry Letters
Appears in Collections:Artigo de Periódico

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.